| Returns | 1W : 0.8% , 1M : -0%,1Y : 8.5% |
| Peers & Returns | 1W | 1M | 1Y |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | 0.8% | -0% | 8.5% |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 2% | 4.1% | 55.6% |
| DR REDDYS LABORATORIES LTD | -0.8% | -0.5% | 45.1% |
| DIVIS LABORATORIES LTD | 0.9% | 1.3% | 60.4% |
| CIPLA LTD | 2.9% | 0.8% | 87.3% |
| BIOCON LTD | 2% | 4.8% | 32.2% |
| AUROBINDO PHARMA LTD | 2.9% | -3.8% | 68.2% |
| LUPIN LTD | 4.7% | 6.7% | 54.3% |
| TORRENT PHARMACEUTICALS LTD | -0.3% | -2.5% | 12.2% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
225.71
P/E Calculated based on EPS of 6.5
[ Mar2020 - Standalone Results ] 13.51
P/B Calculated based on Book Value of 108.62
[ Mar2020 - Standalone Results ] 8.06
P/S Calculated based on Revenues of 3085.31 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
58% 20% 15% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
